# Tamrisa: Pharmaceuticals, Paris, France

> Tamrisa: Tamrisa is a French pharmaceutical company based in Paris, focused on combating antimicrobial resistance. Based in Paris, France. Founded 2024.

Source: https://millionrounds.com/startup/tamrisa (Millionrounds; every figure on the page links to its filing or article)

France · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Tamrisa

Tamrisa is a French pharmaceutical company based in Paris, focused on combating antimicrobial resistance.

Funding reported Last round: Venture (Round not Specified)

Pharmaceuticals Paris, France

Company summary

- **Founded:** 2024 2 years old
- **Team:** 17 11 to 50 people
- **Funding reported:** 7.8M as listed, currency not stated
- **Last round:** Venture (Round not Specified) Jan 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Tamrisa has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Tamrisa

Tamrisa is a French pharmaceutical company based in Paris, focused on combating antimicrobial resistance.

Founded around 2023–2024, it is dedicated to developing innovative solutions in line with World Health Organization guidelines. The company aims to create a sustainable response to resistant infections through its development, commercialization, and access strategies. Tamrisa specializes in pharmaceutical development and commercialization for anti-infective therapies. It has built a portfolio of eight long-proven antibiotics that are registered and available in over 40 countries through distribution partners. Additionally, the company is developing TMR010, a novel intravenous drug designed to target infections caused by carbapenem-resistant Enterobacterales.

## What company datasets say Tamrisa raised

Funding, as reported

Reported in all **7.8M** in the source's currency

Last round **Venture (Round not Specified)**

Last round size **7.8M**

Last round date **Jan 2020**

## The company, in detail

What they build

Known for

medical pharmaceuticals pharmaceutical manufacturing

Built with from their website

Apache Viewport Meta Microsoft Exchange Microsoft 365 Apps & Services Nuxtjs Mobile Friendly Open Graph Swiper Microsoft Exchange Online VueJS

+4 more

Microsoft 365 Apache HTTP Server Outlook Microsoft Email Providers

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 541714, 325412, SIC 2836, 2834
- **Region:** Ile-de-France

## Pharmaceuticals in France

Startups like it

- [**Unither Pharmaceuticals** Paris · founded 1993](https://millionrounds.com/startup/unither-pharmaceuticals)
- [**Biose Industrie** Aurillac · founded 1951](https://millionrounds.com/startup/biose-industrie)
- [**Veracyte Biopharma Services** Marseille · founded 2015](https://millionrounds.com/startup/veracyte-biopharma-services)
- [**Exeliom Biosciences** Dijon · founded 2016](https://millionrounds.com/startup/exeliom-biosciences)
- [**Pierre Fabre Laboratories** Toulouse · founded 1962](https://millionrounds.com/startup/pierre-fabre-laboratories)
- [**Futura Gaïa** Rodilhan · founded 2019](https://millionrounds.com/startup/futura-ga-a)
- [**BIODOL THERAPEUTICS** Montarnaud · founded 2015](https://millionrounds.com/startup/biodol-therapeutics)
- [**BIOPHTA** Paris · founded 2020](https://millionrounds.com/startup/biophta)

## Is this your company?

Add your raise, your deck and your story, and put Tamrisa in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)